Clinical Trial Update: A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating combination HIV-specific broadly neutralizing monoclonal antibodies with antiretroviral therapy initiated during acute HI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Broadly neutralizing monoclonal antibodies (bNAbs) (broadly neutralizing monoclonal antibodies)
• antiretroviral therapy (ART) (antiretroviral therapy)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acute HIV Infection | Phase 2 | Status: RECRUITING